Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia — Stella

Home/Schizophrenia and Related Disorders/

View on ClinicalTrials.gov

Recruiting

Back to Schizophrenia and Related Disorders trials

Trial locations(1 site)

Hong Kong

Queen Mary Hospital, Hong Kong

Key details

Sponsor

The University of Hong Kong

Enrollment target

~10 participants

Started

February 2022

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.